News for Myovant Sciences Ltd. (71M.F)

Myovant Sciences Ltd. (NYSE:MYOV) Q3 2020 Earnings Conference Call February 11, 2021, 08:30 AM ET Company Participants Ryan Crowe - Vice President of Investor Relations Dave Marek - Chief...

Shares of Myovant Sciences (NYSE:MYOV) moved higher by 0.3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 2...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A acti...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO ...

Tuesday afternoon’s analyst upgrades and downgrades included Citigroup, Goldman Sachs, JPMorgan and Tesla.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja...

BASEL, Switzerland, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, ...